| |||||||
ShanghaiTech University Knowledge Management System
Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis | |
Pan, Limin1,2,3; Peng, Haibao4; Lee, Bowon1,2; Zhao, Jiaxu4; Shen, Xiulian3; Yan, Ximei3; Hua, Yipeng3,5 ![]() | |
2023 | |
发表期刊 | ADVANCED MATERIALS (IF:27.4[JCR-2023],30.2[5-Year]) |
ISSN | 0935-9648 |
EISSN | 1521-4095 |
卷号 | 36期号:5 |
发表状态 | 已发表 |
DOI | 10.1002/adma.202305394 |
摘要 | Lysosomes are critical in modulating the progression and metastasis for various cancers. There is currently an unmet need for lysosomal alkalizers that can selectively and safely alter the pH and inhibit the function of cancer lysosomes. Here an effective, selective, and safe lysosomal alkalizer is reported that can inhibit autophagy and suppress tumors in mice. The lysosomal alkalizer consists of an iron oxide core that generates hydroxyl radicals (•OH) in the presence of excessive H+ and hydrogen peroxide inside cancer lysosomes and cerium oxide satellites that capture and convert •OH into hydroxide ions. Alkalized lysosomes, which display impaired enzyme activity and autophagy, lead to cancer cell apoptosis. It is shown that the alkalizer effectively inhibits both local and systemic tumor growth and metastasis in mice. This work demonstrates that the intrinsic properties of nanoparticles can be harnessed to build effective lysosomal alkalizers that are both selective and safe. © 2023 Wiley-VCH GmbH. |
关键词 | Cell death Cerium oxide Diseases Enzyme activity Iron oxides Mammals Pathology Tumors Autophagy Cancer metastasis Cancer progression Catalytic nanoparticle Enzymes activity Hydroxide ions Hydroxyl radicals Lysosome alkalization Metastasis Tumor therapy |
收录类别 | EI |
语种 | 英语 |
出版者 | John Wiley and Sons Inc |
EI入藏号 | 20234915164334 |
EI主题词 | Nanoparticles |
EI分类号 | 461.2 Biological Materials and Tissue Engineering ; 461.6 Medicine and Pharmacology ; 461.9 Biology ; 761 Nanotechnology ; 804.2 Inorganic Compounds ; 933 Solid State Physics |
原始文献类型 | Article in Press |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/347920 |
专题 | 生命科学与技术学院 生命科学与技术学院_博士生 生命科学与技术学院_本科生 |
通讯作者 | Chi, Yudan; Nam, Jwa-Min; Hyeon, Taeghwan; Liu, Jianan |
作者单位 | 1.Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul; 08826, Korea, Republic of; 2.School of Chemical and Biological Engineering, and Institute of Chemical Processes, Seoul National University, Seoul; 08826, Korea, Republic of; 3.Institute of Neuroscience, State Key Laboratory of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai; 200031, China; 4.Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai; 200032, China; 5.School of Life Science and Technology, ShanghaiTech University, Shanghai; 201210, China; 6.Department of Bionano Engineering, Hanyang University, Ansan; 15588, Korea, Republic of; 7.Department of Chemistry, Seoul National University, Seoul; 08826, Korea, Republic of; 8.Department of Radiology, Cancer Hospital/Institute and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai; 200032, China; 9.University of Chinese Academy of Sciences, Beijing; 100049, China |
推荐引用方式 GB/T 7714 | Pan, Limin,Peng, Haibao,Lee, Bowon,et al. Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis[J]. ADVANCED MATERIALS,2023,36(5). |
APA | Pan, Limin.,Peng, Haibao.,Lee, Bowon.,Zhao, Jiaxu.,Shen, Xiulian.,...&Liu, Jianan.(2023).Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis.ADVANCED MATERIALS,36(5). |
MLA | Pan, Limin,et al."Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis".ADVANCED MATERIALS 36.5(2023). |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。